Pongo abelii (Sumatran orangutan): 100450988
Help
Entry
100450988 CDS
T01416
Symbol
MAP2K2
Name
(RefSeq) dual specificity mitogen-activated protein kinase kinase 2 isoform X1
KO
K04369
mitogen-activated protein kinase kinase 2 [EC:
2.7.12.2
]
Organism
pon
Pongo abelii (Sumatran orangutan)
Pathway
pon01521
EGFR tyrosine kinase inhibitor resistance
pon01522
Endocrine resistance
pon04010
MAPK signaling pathway
pon04012
ErbB signaling pathway
pon04014
Ras signaling pathway
pon04015
Rap1 signaling pathway
pon04022
cGMP-PKG signaling pathway
pon04024
cAMP signaling pathway
pon04066
HIF-1 signaling pathway
pon04068
FoxO signaling pathway
pon04071
Sphingolipid signaling pathway
pon04072
Phospholipase D signaling pathway
pon04140
Autophagy - animal
pon04148
Efferocytosis
pon04150
mTOR signaling pathway
pon04151
PI3K-Akt signaling pathway
pon04210
Apoptosis
pon04218
Cellular senescence
pon04270
Vascular smooth muscle contraction
pon04370
VEGF signaling pathway
pon04371
Apelin signaling pathway
pon04540
Gap junction
pon04550
Signaling pathways regulating pluripotency of stem cells
pon04613
Neutrophil extracellular trap formation
pon04620
Toll-like receptor signaling pathway
pon04650
Natural killer cell mediated cytotoxicity
pon04660
T cell receptor signaling pathway
pon04662
B cell receptor signaling pathway
pon04664
Fc epsilon RI signaling pathway
pon04720
Long-term potentiation
pon04722
Neurotrophin signaling pathway
pon04730
Long-term depression
pon04810
Regulation of actin cytoskeleton
pon04910
Insulin signaling pathway
pon04912
GnRH signaling pathway
pon04915
Estrogen signaling pathway
pon04916
Melanogenesis
pon04917
Prolactin signaling pathway
pon04919
Thyroid hormone signaling pathway
pon04921
Oxytocin signaling pathway
pon04926
Relaxin signaling pathway
pon04929
GnRH secretion
pon04934
Cushing syndrome
pon04935
Growth hormone synthesis, secretion and action
pon05010
Alzheimer disease
pon05022
Pathways of neurodegeneration - multiple diseases
pon05132
Salmonella infection
pon05135
Yersinia infection
pon05160
Hepatitis C
pon05161
Hepatitis B
pon05163
Human cytomegalovirus infection
pon05164
Influenza A
pon05165
Human papillomavirus infection
pon05166
Human T-cell leukemia virus 1 infection
pon05167
Kaposi sarcoma-associated herpesvirus infection
pon05170
Human immunodeficiency virus 1 infection
pon05200
Pathways in cancer
pon05205
Proteoglycans in cancer
pon05206
MicroRNAs in cancer
pon05207
Chemical carcinogenesis - receptor activation
pon05208
Chemical carcinogenesis - reactive oxygen species
pon05210
Colorectal cancer
pon05211
Renal cell carcinoma
pon05213
Endometrial cancer
pon05214
Glioma
pon05215
Prostate cancer
pon05216
Thyroid cancer
pon05218
Melanoma
pon05219
Bladder cancer
pon05220
Chronic myeloid leukemia
pon05221
Acute myeloid leukemia
pon05223
Non-small cell lung cancer
pon05224
Breast cancer
pon05225
Hepatocellular carcinoma
pon05226
Gastric cancer
pon05230
Central carbon metabolism in cancer
pon05231
Choline metabolism in cancer
pon05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
KEGG Orthology (KO) [BR:
pon00001
]
09130 Environmental Information Processing
09132 Signal transduction
04014 Ras signaling pathway
100450988 (MAP2K2)
04015 Rap1 signaling pathway
100450988 (MAP2K2)
04066 HIF-1 signaling pathway
100450988 (MAP2K2)
04068 FoxO signaling pathway
100450988 (MAP2K2)
04072 Phospholipase D signaling pathway
100450988 (MAP2K2)
04071 Sphingolipid signaling pathway
100450988 (MAP2K2)
04024 cAMP signaling pathway
100450988 (MAP2K2)
04022 cGMP-PKG signaling pathway
100450988 (MAP2K2)
04151 PI3K-Akt signaling pathway
100450988 (MAP2K2)
04150 mTOR signaling pathway
100450988 (MAP2K2)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
100450988 (MAP2K2)
04148 Efferocytosis
100450988 (MAP2K2)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
100450988 (MAP2K2)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
100450988 (MAP2K2)
04620 Toll-like receptor signaling pathway
100450988 (MAP2K2)
04650 Natural killer cell mediated cytotoxicity
100450988 (MAP2K2)
04660 T cell receptor signaling pathway
100450988 (MAP2K2)
04662 B cell receptor signaling pathway
100450988 (MAP2K2)
04664 Fc epsilon RI signaling pathway
100450988 (MAP2K2)
09152 Endocrine system
04929 GnRH secretion
100450988 (MAP2K2)
04915 Estrogen signaling pathway
100450988 (MAP2K2)
04917 Prolactin signaling pathway
100450988 (MAP2K2)
04921 Oxytocin signaling pathway
100450988 (MAP2K2)
04926 Relaxin signaling pathway
100450988 (MAP2K2)
04935 Growth hormone synthesis, secretion and action
100450988 (MAP2K2)
04919 Thyroid hormone signaling pathway
100450988 (MAP2K2)
09156 Nervous system
04720 Long-term potentiation
100450988 (MAP2K2)
04730 Long-term depression
100450988 (MAP2K2)
04722 Neurotrophin signaling pathway
100450988 (MAP2K2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100450988 (MAP2K2)
05206 MicroRNAs in cancer
100450988 (MAP2K2)
05205 Proteoglycans in cancer
100450988 (MAP2K2)
05207 Chemical carcinogenesis - receptor activation
100450988 (MAP2K2)
05208 Chemical carcinogenesis - reactive oxygen species
100450988 (MAP2K2)
05230 Central carbon metabolism in cancer
100450988 (MAP2K2)
05231 Choline metabolism in cancer
100450988 (MAP2K2)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100450988 (MAP2K2)
09162 Cancer: specific types
05210 Colorectal cancer
100450988 (MAP2K2)
05225 Hepatocellular carcinoma
100450988 (MAP2K2)
05226 Gastric cancer
100450988 (MAP2K2)
05214 Glioma
100450988 (MAP2K2)
05216 Thyroid cancer
100450988 (MAP2K2)
05221 Acute myeloid leukemia
100450988 (MAP2K2)
05220 Chronic myeloid leukemia
100450988 (MAP2K2)
05218 Melanoma
100450988 (MAP2K2)
05211 Renal cell carcinoma
100450988 (MAP2K2)
05219 Bladder cancer
100450988 (MAP2K2)
05215 Prostate cancer
100450988 (MAP2K2)
05213 Endometrial cancer
100450988 (MAP2K2)
05224 Breast cancer
100450988 (MAP2K2)
05223 Non-small cell lung cancer
100450988 (MAP2K2)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100450988 (MAP2K2)
05170 Human immunodeficiency virus 1 infection
100450988 (MAP2K2)
05161 Hepatitis B
100450988 (MAP2K2)
05160 Hepatitis C
100450988 (MAP2K2)
05164 Influenza A
100450988 (MAP2K2)
05163 Human cytomegalovirus infection
100450988 (MAP2K2)
05167 Kaposi sarcoma-associated herpesvirus infection
100450988 (MAP2K2)
05165 Human papillomavirus infection
100450988 (MAP2K2)
09171 Infectious disease: bacterial
05135 Yersinia infection
100450988 (MAP2K2)
09164 Neurodegenerative disease
05010 Alzheimer disease
100450988 (MAP2K2)
05022 Pathways of neurodegeneration - multiple diseases
100450988 (MAP2K2)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
100450988 (MAP2K2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100450988 (MAP2K2)
01522 Endocrine resistance
100450988 (MAP2K2)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
pon01001
]
100450988 (MAP2K2)
Enzymes [BR:
pon01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.12 Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
2.7.12.2 mitogen-activated protein kinase kinase
100450988 (MAP2K2)
Protein kinases [BR:
pon01001
]
Serine/threonine kinases: STE group
STE7 family
100450988 (MAP2K2)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
Pkinase_fungal
Kinase-like
Haspin_kinase
CAMSAP_CC1
Kdo
Seadorna_VP7
APH
Motif
Other DBs
NCBI-GeneID:
100450988
NCBI-ProteinID:
XP_024093085
LinkDB
All DBs
Position
20:complement(4001864..4037714)
Genome browser
AA seq
400 aa
AA seq
DB search
MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQ
KAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ
VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG
LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQ
GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP
PGRPISGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL
KMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV
NT seq
1203 nt
NT seq
+upstream
nt +downstream
nt
atgctggcccggaggaagccggtgctgccggcgctcaccatcaaccctaccatcgccgag
ggcccgtcccctaccagcgagggcgcctccgaggcaaacctggtggacctgcagaagaag
ctggaggagctagaacttgacgagcagcagaagaagcgactggaagcctttctcacccag
aaagccaaggtcggcgaactcaaagacgatgacttcgaaaggatctcagagctgggcgcg
ggcaacggcggggtggtcaccaaagtccagcacagaccctcaggcctcatcatggccagg
aagctgatccaccttgagatcaagccggccatccggaaccagatcatccgcgagctgcag
gtcctgcacgagtgcaactcgccgtacatcgtgggcttctacggggccttctacagcgat
ggggagatcagcatctgcatggagcacatggatggcggctccctggaccaggtgctgaaa
gaggccaagaggattcccgaggagatcctggggaaagtcagcatcgcggttctccggggc
ttggcgtacctccgagagaagcaccagatcatgcaccgagatgtgaagccctccaacatc
ctcgtgaactctagaggggagatcaagctgtgtgactttggggtgagcggccagctcatc
gactccatggccaactccttcgtgggcacgcgctcctacatggctccggagcggttgcag
ggcacacattactcggtgcagtcggacatctggagcatgggcctgtccctggtggagctg
gccatcggaaggtaccccattcccccgcccgacgccaaggagctggaggccatctttggc
cggcccgtggtcgacggggaagaaggagagcctcacagcatctcgcctcggccgaggccc
cccgggcgccccatcagcggtcacgggatggacagccggcccgccatggccatctttgaa
ctgctggactatattgtgaacgagccacctcctaagctgcccaacggggtgttcaccccc
gacttccaggagtttgtcaataaatgcctcatcaagaacccagcggagcgggcggacctg
aagatgctcacaaaccacaccttcatcaagcggtccgaggtggaagaagtggattttgcc
ggctggttgtgtaaaaccctgcggctgaaccagcccggcacacccacgcgcaccgctgtg
tga
DBGET
integrated database retrieval system